{"id":"https://openalex.org/W2553729861","doi":null,"title":"Blinded Bayesian Adverse Event Monitoring","display_name":"Blinded Bayesian Adverse Event Monitoring","publication_year":2015,"publication_date":"2015-01-01","ids":{"openalex":"https://openalex.org/W2553729861","mag":"2553729861"},"language":"en","primary_location":{"id":"mag:2553729861","doi":null,"is_oa":false,"landing_page_url":"https://www.bayes-pharma.org/wp-content/uploads/2014/10/poster-sailer-basel-bayes2015.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038483615","display_name":"Oliver Sailer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Oliver Sailer","raw_affiliation_strings":["Boehringer Ingelheim"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067149170","display_name":"Timo Bailer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Timo Bailer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9599999785423279,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.033799998462200165,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10243","display_name":"Statistical Methods and Bayesian Inference","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-event-surveillance","display_name":"adverse event monitoring","score":0.8090000152587891},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.39399999380111694},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.7170000076293945},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.7799999713897705},{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":0.9639999866485596},{"id":"https://openalex.org/keywords/historical-control-data","display_name":"historical control data","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6891840696334839},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.6399147510528564},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6097941994667053},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5784337520599365},{"id":"https://openalex.org/C107673813","wikidata":"https://www.wikidata.org/wiki/Q812534","display_name":"Bayesian probability","level":2,"score":0.5643233060836792},{"id":"https://openalex.org/C207201462","wikidata":"https://www.wikidata.org/wiki/Q182505","display_name":"Bayes' theorem","level":3,"score":0.5342570543289185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5034453272819519},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4598139226436615},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.41456714272499084},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27238255739212036},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.17551115155220032},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.14467039704322815},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.11220359802246094},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0993080735206604}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2553729861","doi":null,"is_oa":false,"landing_page_url":"https://www.bayes-pharma.org/wp-content/uploads/2014/10/poster-sailer-basel-bayes2015.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W651652324","https://openalex.org/W2010622913","https://openalex.org/W2170030318"],"related_works":["https://openalex.org/W2550312131","https://openalex.org/W2474836924","https://openalex.org/W2552093070","https://openalex.org/W4406808723","https://openalex.org/W595536377","https://openalex.org/W2194629532","https://openalex.org/W4416065631","https://openalex.org/W2523893357","https://openalex.org/W7198049889","https://openalex.org/W2800919951"],"abstract_inverted_index":{"6th":[0],"Bayes":[1],"Pharma":[2],"Conference":[3],"19-22":[4],"May":[5],"2015,":[6],"Basel":[7],"Switzerland":[8],"References":[9],"[1]":[10],"Neuenschwander,":[11],"B":[12],"et":[13,31,59],"al.":[14,32,60],"(2010).":[15,33],"Summarizing":[16],"historical":[17],"information":[18],"on":[19],"controls":[20],"in":[21,49,69],"clinical":[22,38],"trials.":[23,39],"Clinical":[24,50],"Trials":[25],"7,":[26],"5\u201318.":[27],"[2]":[28],"Berry,":[29],"SM":[30],"Bayesian":[34,46,93],"adaptive":[35],"methods":[36],"for":[37],"CRC":[40],"press.":[41],"[3]":[42],"Bailer,":[43],"T":[44],"(2014):":[45],"Decision":[47],"Criteria":[48],"Development.":[51],"Master\u2019s":[52],"thesis,":[53],"Ulm":[54],"University.":[55],"[4]":[56],"Reck,":[57],"M":[58],"(2014).":[61],"Docetaxel":[62],"plus":[63,67],"nintedanib":[64],"versus":[65],"docetaxel":[66],"placebo":[68],"patients":[70],"with":[71],"previously":[72],"treated":[73],"non-small-cell":[74],"lung":[75],"cancer":[76],"(LUME-Lung":[77],"1):":[78],"a":[79],"phase":[80],"3,":[81],"double-blind,":[82],"randomised":[83],"controlled":[84],"trial.":[85],"The":[86],"lancet":[87],"oncology":[88],"15,":[89],"143\u2013155.":[90],"ABCD":[91],"Blinded":[92],"Adverse":[94],"Event":[95],"Monitoring":[96],"Oliver":[97],"Sailer*,":[98],"Timo":[99],"Bailer":[100]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-11-30T00:00:00"}